Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
|2||Active, not recruiting||
Resection+Highly Purified CTL Versus Resection Alone for HCC
|3||Active, not recruiting||
Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced Hcc
† Study has passed its completion date and status has not been verified in more than two years.